Skip to main content
Full access
Letters
Published Online: 1 January 2013

Acute Confusion After Minimal Hepatic Encephalopathy

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: We present the case of a 67-year-old man with a history of portal vein thrombosis due to chronic hepatitis B, presenting at the emergency room with acute confusion. Magnetic resonance imaging of the brain revealed hyperintensities in the basal ganglia bilaterally. Neuropsychological testing and electroencephalography confirmed an encephalopathic process. The patient was treated with lactulose and returned to normal. Minimal hepatic encephalopathy (MHE) is a newly-recognized syndrome that could cause episodes of confusion, with the patient being normal between them. Porto-systemic shunting may be the cause of elevated ammonia levels that affect the brain. Management of MHE includes reduction in the production and absorption of ammonia.
FIGURE 1. Axial T1-Weighted Brain MRI Showing Bilateral Basal Ganglia Hyperintensities

Case Report

A 67-year-old normotensive man was admitted for evaluation of acute confusion. His past medical history was remarkable for chronic hepatitis B, complicated by portal vein thrombosis 2 years ago. According to his attending gastroenterologist, he was currently clinically stable, with no overt symptoms or signs of hepatic encephalopathy.
On examination, he was disorientated in space and time and looked anxious and nervous. He had brisk reflexes bilaterally, normal strength, and downgoing plantar reflexes. An urgent brain Computed Tomography (CT) scan was unremarkable. His biochemical and hematological profile was normal except for elevated γ-GT, mildly elevated bilirubin, and thrombocytopenia. T1-weighted brain magnetic resonance imaging (MRI) revealed hyperintensities in the basal ganglia bilaterally (Figure 1). An electroencephalogram (EEG) showed bifrontal slow-wave activity, with a frequency of 2.5 to 5 Hz, suggesting metabolic encephalopathy. Neuropsychological testing results were compatible with an encephalopathic process, showing visuospatial disabilities, slow processing speed, and memory impairment. The patient was treated with lactulose and returned to normal.
Minimal hepatic encephalopathy (MHE) is a newly-recognized syndrome that could cause episodes of confusion with the patient being normal between them.1 A diagnosis could be reached with neurophysiology (EEG, evoked potentials), and neuropsychological assessment, because the patients do not present clinical signs of overt hepatic encephalopathy.2 In our patient, chronic liver cirrhosis and portal vein thrombosis resulted in shunting of portal venous blood into the systemic circulation. Porto-systemic shunting may be the cause of elevated ammonia levels that affect brain astrocytes, resulting in defective neurotransmission and, eventually, confusion in such patients.3 Management of MHE includes identification and treatment of the precipitating cause as well as reduction in the production and absorption of ammonia.4

Footnote

Authors’ contribution: PI and SM cared for the patient and wrote the manuscript, PM wrote the manuscript, and DK evaluated and revised the manuscript.

References

1.
Bajaj JS: Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14:3609–3615
2.
Montgomery JY, Bajaj JS: Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep 2011; 13:26–33
3.
Felipo V, Urios A, Montesinos E, et al.: Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis 2011; (E-pub ahead of print).
4.
Luo M, Li L, Lu CZ, et al.: Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 2011; 23:1250–1257

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E38
PubMed: 23487227

History

Published online: 1 January 2013
Published in print: Winter 2013

Authors

Details

Panagiotis Ioannidis, M.D, Ph.D.
2nd Department of Neurology AHEPA University Hospital Thessaloniki, Greece
Sofia Michelaki, M.D
2nd Department of Neurology AHEPA University Hospital Thessaloniki, Greece
Pantelis Maiovis, M.D
2nd Department of Neurology AHEPA University Hospital Thessaloniki, Greece
Dimitris Karacostas, M.D, Ph.D.
2nd Department of Neurology AHEPA University Hospital Thessaloniki, Greece

Notes

Correspondence: Pantelis Maiovis, M.D., 2nd Department of Neurology, AHEPA University Hospital, Thessaloniki, Greece; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share